Literature DB >> 2898010

Aspartic acid aminotransferase activity is increased in actively spiking compared with non-spiking human epileptic cortex.

S J Kish1, L M Dixon, A L Sherwin.   

Abstract

Increased concentration of the excitatory neurotransmitter aspartic acid in actively spiking human epileptic cerebral cortex was recently described. In order to further characterise changes in the aspartergic system in epileptic brain, the behaviour of aspartic acid aminotransferase (AAT), a key enzyme involved in aspartic acid metabolism has now been examined. Electrocorticography performed during surgery was employed to identify cortical epileptic spike foci in 16 patients undergoing temporal lobectomy for intractable seizures. Patients with spontaneously spiking lateral temporal cortex (n = 8) were compared with a non-spiking control group (n = 8) of patients in whom the epileptic lesions were confined to the hippocampus sparing the temporal convexity. Mean activity of AAT in spiking cortex was significantly elevated by 16-18%, with aspartic acid concentration increased by 28%. Possible explanations for the enhanced AAT activity include increased proliferation of cortical AAT-containing astrocytes at the spiking focus and/or a generalised increase in neuronal or extraneuronal metabolism consequent to the ongoing epileptic discharge. It is suggested that the data provide additional support for a disturbance of central excitatory aspartic acid mechanisms in human epileptic brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898010      PMCID: PMC1032973          DOI: 10.1136/jnnp.51.4.552

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Activity of acetylcholine system in human epileptogenic focus.

Authors:  D B TOWER; K A C ELLIOTT
Journal:  J Appl Physiol       Date:  1952-02       Impact factor: 3.531

2.  Neurochemical and morphological changes during the development of cobalt-induced epilepsy in the rat.

Authors:  P C Emson; M H Joseph
Journal:  Brain Res       Date:  1975-07-25       Impact factor: 3.252

3.  Excitatory amino acid antagonists as novel anticonvulsants.

Authors:  B Meldrum
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

4.  Free amino acid levels in the cerebrospinal fluid of normal humans and their variation in cases of epilepsy and Spielmeyer-Vogt-Batten disease.

Authors:  C M Plum
Journal:  J Neurochem       Date:  1974-09       Impact factor: 5.372

5.  [Metabolic studies of epileptic seizures. The concentration of free amino acids in cerebral tissue prior to and during cerebral seizures].

Authors:  P Wiechert; G Göllnitz
Journal:  J Neurochem       Date:  1969-06       Impact factor: 5.372

6.  Glutamate-aspartate transaminase.

Authors:  A J Cooper
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

7.  Close correlation between changing content of specific amino acids in epileptogenic cortex of cats, and severity of epilepsy.

Authors:  N M Van Gelder; A Courtois
Journal:  Brain Res       Date:  1972-08-25       Impact factor: 3.252

8.  A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices.

Authors:  C E Herron; R Williamson; G L Collingridge
Journal:  Neurosci Lett       Date:  1985-11-11       Impact factor: 3.046

9.  Bursting in human epileptogenic neocortex is depressed by an N-methyl-D-aspartate antagonist.

Authors:  M Avoli; A Olivier
Journal:  Neurosci Lett       Date:  1987-05-06       Impact factor: 3.046

10.  Differential changes in the content of amino acid neurotransmitters in discrete regions of the rat brain prior to the onset and during the course of homocysteine-induced seizures.

Authors:  I C Allen; A Grieve; R Griffiths
Journal:  J Neurochem       Date:  1986-05       Impact factor: 5.372

View more
  4 in total

1.  Beta-DL-methylene-aspartate, an inhibitor of aspartate aminotransferase, potently inhibits L-glutamate uptake into astrocytes.

Authors:  A S Bender; D M Woodbury; H S White
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

2.  Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy.

Authors:  S Bothwell; G E Meredith; J Phillips; H Staunton; C Doherty; E Grigorenko; S Glazier; S A Deadwyler; C A O'Donovan; M Farrell
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 3.  Metabolic parameters of epilepsy: adjuncts to established antiepileptic drug therapy.

Authors:  Nico M van Gelder; Allan L Sherwin
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

4.  Studying Enzymes by In Vivo C Magnetic Resonance Spectroscopy.

Authors:  Su Xu; Jun Shen
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-10-01       Impact factor: 9.795

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.